tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCRX Stock Latest News

Doma Perpetual reports 5.7% stake in Pacira, seeks influence
The FlyDoma Perpetual reports 5.7% stake in Pacira, seeks influence
5d ago
PCRX
Pacira up 4% to $24.71 after activist Doma Perpetual takes stake
PremiumThe Fly
Pacira up 4% to $24.71 after activist Doma Perpetual takes stake
5d ago
PCRX
Pacira’s Earnings Call Highlights Growth and Strategy
PremiumCompany Announcements
Pacira’s Earnings Call Highlights Growth and Strategy
7d ago
PCRX
Optimistic Growth Prospects for Pacira Pharmaceuticals Amidst Recent Challenges
PremiumRatings
Optimistic Growth Prospects for Pacira Pharmaceuticals Amidst Recent Challenges
8d ago
PCRX
Pacira BioSciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Pacira BioSciences Reports Q2 2025 Financial Results
8d ago
PCRX
Pacira narrows FY25 revenue view to $730M-$750M from $725M-$765M
PremiumThe FlyPacira narrows FY25 revenue view to $730M-$750M from $725M-$765M
8d ago
PCRX
Pacira reports Q2 EPS 74c, consensus 71c
Premium
The Fly
Pacira reports Q2 EPS 74c, consensus 71c
8d ago
PCRX
Is PCRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is PCRX a Buy, Before Earnings?
11d ago
PCRX
Pacira upgraded to Buy from Hold at Truist
PremiumThe Fly
Pacira upgraded to Buy from Hold at Truist
20d ago
JNJ
PCRX
Pacira collabs with J&J’s MedTech to expand market reach of ZILRETTA
PremiumThe Fly
Pacira collabs with J&J’s MedTech to expand market reach of ZILRETTA
23d ago
JNJ
PCRX
Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency
PremiumCompany Announcements
Pacira Pharmaceuticals Implements Workforce Reduction for Efficiency
1M ago
8K
PCRX
Pacira Pharmaceuticals Secures New $300M Credit Facility
PremiumCompany Announcements
Pacira Pharmaceuticals Secures New $300M Credit Facility
1M ago
8K
PCRX
Pacira debuts film spotlighting patient journey to pain relief
PremiumThe FlyPacira debuts film spotlighting patient journey to pain relief
2M ago
PCRX
Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan
Premium
Company Announcements
Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan
2M ago
8K
PCRX
Pacira announces new long-term follow-up data from Phase 1 trial on PCRX-201
Premium
The Fly
Pacira announces new long-term follow-up data from Phase 1 trial on PCRX-201
2M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
2M ago
PCRX
Pacira presents new data on PCRX-201
PremiumThe Fly
Pacira presents new data on PCRX-201
3M ago
PCRX
Pacira’s Earnings Call Highlights Strategic Wins and Growth
PremiumCompany Announcements
Pacira’s Earnings Call Highlights Strategic Wins and Growth
3M ago
PCRX
Pacira BioSciences Reports Q1 2025 Financial Results
PremiumCompany Announcements
Pacira BioSciences Reports Q1 2025 Financial Results
3M ago
PCRX
Pacira reports Q1 EPS 65c, consensus 60c
PremiumThe FlyPacira reports Q1 EPS 65c, consensus 60c
3M ago
PCRX
Pacira sees FY25 revenue $725M-$765M, consensus $752.9M
Premium
The Fly
Pacira sees FY25 revenue $725M-$765M, consensus $752.9M
3M ago
PCRX
Pacira announces new data from Phase 1 study of PCRX-201
Premium
The Fly
Pacira announces new data from Phase 1 study of PCRX-201
3M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >